Live
Black Hat USAAI BusinessBlack Hat AsiaAI BusinessEarly Career Award recipient Aleksandra Ćiprijanović aims to create universal AI analysis framework - Fermilab (.gov)Google News: AIExclusive: Miravoice, Builder Of An AI ‘Interviewer’ To Conduct Phone Surveys, Raises $6.3MCrunchbase NewsMoltbook risks: The dangers of AI-to-AI interactions in health carePhys.org AIMaul: Shadow Lord Will Return for Season 2GizmodoMicrosoft Aims to Create Large Cutting-Edge AI Models By 2027Bloomberg TechnologyHow Disney Imagineers are using AI and robotics to reshape the company’s theme parksFast Company TechA jury says Meta and Google hurt a kid. What now?The Verge AII have always seen myself as ‘progressive’ – but with AI it’s time to hit the brakes - The GuardianGoogle News: AIOpenAI Teams Up with Smartly to Create Chatty Ads Inside ChatGPT - TipRanksGoogle News: ChatGPTDOJ to Appeal Court Order Halting Trump’s Ban on Anthropic AIBloomberg TechnologyCapacity and speed: why TikTok shelved its second Irish data centreSilicon RepublicBlack Hat USAAI BusinessBlack Hat AsiaAI BusinessEarly Career Award recipient Aleksandra Ćiprijanović aims to create universal AI analysis framework - Fermilab (.gov)Google News: AIExclusive: Miravoice, Builder Of An AI ‘Interviewer’ To Conduct Phone Surveys, Raises $6.3MCrunchbase NewsMoltbook risks: The dangers of AI-to-AI interactions in health carePhys.org AIMaul: Shadow Lord Will Return for Season 2GizmodoMicrosoft Aims to Create Large Cutting-Edge AI Models By 2027Bloomberg TechnologyHow Disney Imagineers are using AI and robotics to reshape the company’s theme parksFast Company TechA jury says Meta and Google hurt a kid. What now?The Verge AII have always seen myself as ‘progressive’ – but with AI it’s time to hit the brakes - The GuardianGoogle News: AIOpenAI Teams Up with Smartly to Create Chatty Ads Inside ChatGPT - TipRanksGoogle News: ChatGPTDOJ to Appeal Court Order Halting Trump’s Ban on Anthropic AIBloomberg TechnologyCapacity and speed: why TikTok shelved its second Irish data centreSilicon Republic
AI NEWS HUBbyEIGENVECTOREigenvector

DPD-Cancer: Explainable Graph-based Deep Learning for Small Molecule Anti-Cancer Activity Prediction

arXivMarch 30, 202610 min read0 views
Source Quiz

arXiv:2603.26114v1 Announce Type: cross Abstract: Accurate drug response prediction is a critical bottleneck in computational biochemistry, limited by the challenge of modelling the interplay between molecular structure and cellular context. In cancer research, this is acute due to tumour heterogeneity and genomic variability, which hinder the identification of effective therapies. Conventional approaches often fail to capture non-linear relationships between chemical features and biological outcomes across diverse cell lines. To address this, we introduce DPD-Cancer, a deep learning method ba — Magnus H. Str{\o}mme, Alex G. C. de S\'a, David B. Ascher

View PDF

Abstract:Accurate drug response prediction is a critical bottleneck in computational biochemistry, limited by the challenge of modelling the interplay between molecular structure and cellular context. In cancer research, this is acute due to tumour heterogeneity and genomic variability, which hinder the identification of effective therapies. Conventional approaches often fail to capture non-linear relationships between chemical features and biological outcomes across diverse cell lines. To address this, we introduce DPD-Cancer, a deep learning method based on a Graph Attention Transformer (GAT) framework. It is designed for small molecule anti-cancer activity classification and the quantitative prediction of cell-line specific responses, specifically growth inhibition concentration (pGI50). Benchmarked against state-of-the-art methods (pdCSM-cancer, ACLPred, and MLASM), DPD-Cancer demonstrated superior performance, achieving an Area Under ROC Curve (AUC) of up to 0.87 on strictly partitioned NCI60 data and up to 0.98 on ACLPred/MLASM datasets. For pGI50 prediction across 10 cancer types and 73 cell lines, the model achieved Pearson's correlation coefficients of up to 0.72 on independent test sets. These findings confirm that attention-based mechanisms offer significant advantages in extracting meaningful molecular representations, establishing DPD-Cancer as a competitive tool for prioritising drug candidates. Furthermore, DPD-Cancer provides explainability by leveraging the attention mechanism to identify and visualise specific molecular substructures, offering actionable insights for lead optimisation. DPD-Cancer is freely available as a web server at: this https URL.

Subjects:

Machine Learning (cs.LG); Artificial Intelligence (cs.AI)

Cite as: arXiv:2603.26114 [cs.LG]

(or arXiv:2603.26114v1 [cs.LG] for this version)

https://doi.org/10.48550/arXiv.2603.26114

arXiv-issued DOI via DataCite

Submission history

From: Alex De Sá [view email] [v1] Fri, 27 Mar 2026 07:00:12 UTC (1,543 KB)

Was this article helpful?

Sign in to highlight and annotate this article

AI
Ask AI about this article
Powered by Eigenvector · full article context loaded
Ready

Conversation starters

Ask anything about this article…

Daily AI Digest

Get the top 5 AI stories delivered to your inbox every morning.

More about

researchpaperarxiv

Knowledge Map

Knowledge Map
TopicsEntitiesSource
DPD-Cancer:…researchpaperarxivaiartificial-…arXiv

Connected Articles — Knowledge Graph

This article is connected to other articles through shared AI topics and tags.

Knowledge Graph100 articles · 230 connections
Scroll to zoom · drag to pan · click to open

Discussion

Sign in to join the discussion

No comments yet — be the first to share your thoughts!

More in Research Papers